-
*Akihito YAMASHITA
Toxicology Group II, Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd. Department of Pharmacogenomics, Mie University, Graduate School of Medicine
-
Jiro DEGUCHI
Toxicology Group II, Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd.
-
Toru YAMADA
Toxicology Group II, Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd.
-
Yuhei NISHIMURA
Department of Pharmacogenomics, Mie University, Graduate School of Medicine
-
Toshio TANAKA
Department of Pharmacogenomics, Mie University, Graduate School of Medicine